감염병 실험실의 생물안전 위해성관리 전략 수립
Construction of biosafety risk management strategy for infectious disease laboratory
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
본 논문은 국내 감염병 실험실의 생물안전 위해성관리 전략 수립을 위한 연구이다. 이를 위해 Alexander와 Marshall의 위해성 관리전략 수립모델을 수정하여 적용하였다. 모델의 수정을 위해 경영컨설팅 방법론에 의거하여 연구방향을 설정하고 현상을 분석한 후 과제를 도출하였고, 수정된 모델을 반영한 연구모델을 구성하였다. 이후 연구모델을 유해성평가 기법인 HAZOP을 통해 분석하여 감염병 실험실의 생물안전 위해성관리 논리모델을 구축하였다. 수립된 논리모델은 감염병 실험실의 세부적인 과업 도출 및 구체적인 관리 이행을 용이하게 할 것으로 기대된다.
Abstract
In this paper, it was research for the development of biosafety risk management strategy of the domestic infection disease laboratory. So it was applied by modifying the model of planning and risk management strategy of Marshall & Alexander. Based on the management consulting methodology for modifying the model, we set the direction of the research, analyzed the current situation to extract the tasks. And, I have configured the research model that reflects the model that has been modified. And after I constructed the logical model of biosafety risk management of a infectious diseases laboratory through the HAZOP analysis that was a hazard assessment method. The logical model is expected facilitating a transition to the management and the specific detailed task extraction for laboratory infections.
참고문헌 (20)
- 질병관리본부, "기관생물안전위원회 구성․운영지침" (2013), 보건복지부
- ABSA Education, "ABSA Top5 Training Needs Survey Results" (2014), American Biological Safety Association
- ACS(American Chemical Society), "Understanding risk anaysis, guide for health, safety and environmental policy making" (1998), American Chemical Society
- Anthony W Edwards, "Likelihood" (1972), Cambridge UP
- Arben Mullai, "Risk management system-risk assessment frameworks and techniques" (2006), DaGoB publication series
- BCH(Biosafety Clearing House), "Guidance on Risk Assessment of Living Modified Organisms" (2000), Biosafety Clearing House
- Risk Management in the National Health Service in England, "Emslie E", Department of Health, Sydney, Australia, ~, pp.Report to ISO General Assembly (2001)
- Survey on the awareness and usage of Laboratory biorisk management CWA 15793:2011 and its guidance document CWA 16393:2012, "European BioSafety Association", European BioSafety Association, ~ (2013)
- Directorate General Ⅲ of the European Commission, "EC(European Commission)", ~, pp.Directive 76 (1997), 769[DOI]
- Hillson, "Developing Effective Risk Responses", Proceedings of the 30th Annual Project Management Institute Seminars and Symposium, Philadelphia, USA, 1999 (1999)
- IEC(International Electro-technical Commission), "Dependability management – Risk analysis of technological systems" (1995), IEC, Geneva
- Kamalesh Panthi, "Risk Matrix as a Guide to Develop Risk Response Strategies", Proceedings of 43rd ASC National Annual Conference, Arizona, USA, 2007 (2007)
- 이경민, "A Survey on Laboratory Biosafety Status of Public Healthcare Centers in Korea", Journal of Bacteriology and Virology, 43(3), pp.217~228 (2013), 대한미생물학회[DOI]
- OGTR(Office of the Gene Technology Regulator), "Risk Analysis Framework" (2005), Office of the Gene Technology Regulator
- Risk: Analysis, Perception and Management, "RSSG(Royal Society Study Group, UK)", Report of the Royal Society Study Group, London, ~ (1992)
- Silvianita, Mohd, "Critical Review of a Risk Assessment Method and its Applications", International Conference on Financial Management and Economics, 11, pp.83~87 (2011)
- Pine y, C., "Risk Response Planning: Selecting the Right Strategy", Fifth European Project Management Conference, PMI Europe, 2002 (2002)
- WHO, "Laboratory Biorisk Management Strategic Framework for Action 2012–2016" (2012), World Health Organization
- "2013년 실험실 안전성 모니터링 지도결과 분석" (2014), 미래창조과학부[URL]
- "The Risk Matrix: Illustrating the Importance of Risk Management Strategies" (2014)[URL]